Modulation of the Gut Microbiota in Memory Impairment and Alzheimer’s Disease via the Inhibition of the Parasympathetic Nervous System

Abstract

The gut microbiota has been demonstrated to play a critical role in maintaining cognitive function via the gut-brain axis, which may be related to the parasympathetic nervous system (PNS). However, the exact mechanism remains to be determined. We investigated that patients with mild cognitive impairment (MCI) and Alzheimer’s disease (AD) could exhibit an altered gut microbiota through the suppression of the PNS, compared to the healthy individuals, using the combined gut microbiota data from previous human studies. The hypothesis was validated in rats to suppress the PNS by scopolamine injections. The human fecal bacterial FASTA/Q files were selected and combined from four different AD studies (n = 410). All rats had a high-fat diet and treatments for six weeks. The MD rats had memory impairment by scopolamine injection (2 mg/kg body weight; MD, Control) or no memory impairment by saline injection. The scopolamine-injected rats had a donepezil intake as the positive group. In the optimal model generated from the XGboost analysis, Blautia luti, Pseudomonas mucidoiens, Escherichia marmotae, and Gemmiger formicillis showed a positive correlation with MCI while Escherichia fergusonii, Mycobacterium neglectum, and Lawsonibacter asaccharolyticus were positively correlated with AD in the participants with enterotype Bacteroides (ET-B, n = 369). The predominant bacteria in the AD group were negatively associated in the networking analysis with the bacteria in the healthy group of ET-B participants. From the animal study, the relative abundance of Bacteroides and Bilophilia was lower, and that of Escherichia, Blautia, and Clostridium was higher in the scopolamine-induced memory deficit (MD) group than in the normal group. These results suggest that MCI was associated with the PNS suppression and could progress to AD by exacerbating the gut dysbiosis. MCI increased Clostridium and Blautia, and its progression to AD elevated Escherichia and Pseudomonas. Therefore, the modulation of the PNS might be linked to an altered gut microbiota and brain function, potentially through the gut-brain axis.

Selenium- and/or Zinc-Enriched Egg Diet Improves Oxidative Damage and Regulates Gut Microbiota in D-Gal-Induced Aging Mice

“…The intestinal flora of the elderly showed an increase in the abundance of Firmicutes and a decrease in the abundance of Bacteroidetes , and the ratio of the two decreased significantly [ 57 ]. In elderly patients with constipation, the relative abundance of Blautia reduced [ 58 ], while Blautia was positively correlated with mild cognitive impairment [ 59 ] and negatively correlated with TNF-α, IL-6, and IL-1β [ 60 ], which was consistent with our results. Dietary components (including micronutrients) affect gastrointestinal colonization and microflora colonization.…”

Gut microbiota in combination with blood metabolites reveals characteristics of the disease cluster of coronary artery disease and cognitive impairment: a Mendelian randomization study

“…In our study, family Desulfovibrionaceae as well as order Desulfovibrionales were significantly and causally associated with increased risk of AD, and previous clinical studies have corroborated our findings. The study by Hou et al ( 45 ) found higher abundance of family Desulfovibrionaceae and order Desulfovibrionales in AD patients, the same results were found in patients with cognitive impairment in the study by Park et al ( 46 ). Haran et al ( 47 ) combined with machine learning found that a representative species of the sulfate-reducing Desulfovibrio genus (D. fairfieldensis) could serve as a highly significant predictor of AD.…”

Intestinal microecological transplantation for a patient with chronic radiation enteritis: A case report

“…Escherichia fergusonii , a gram-negative bacterium belonging to the genus Escherichia of the family Enterobacteriaceae, is an emerging pathogen with zoonotic potential. Escherichia fergusonii has been isolated from patients with wound infections, urinary tract infections, inflammatory bowel disease, ischemic bowel disease, pancreatic cancer, and Alzheimer's disease; however, its virulence determinants are not well understood[ 9 - 12 ]. Romboutsia timonensis is a pathogenic bacterium first reported in 2016.…”